Low Fluoroscopy Afib Ablation Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2018-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective data collection of patients undergoing Atrial Fibrillation Ablation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Atrial Fibrillation Ablation Registry

NCT04055961

Atrial Fibrillation

UNKNOWN

Affera Global Registry

NCT06026345

Atrial Fibrillation

RECRUITING

AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation

NCT05481359

Atrial Fibrillation, Persistent Atrial Fibrillation Arrhythmias, Cardiac +1 more

COMPLETED

Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success

NCT04229160

Atrial Fibrillation, Persistent

ACTIVE_NOT_RECRUITING NA

Atrial Fibrillation Ablation Pilot Study

NCT00744835

Atrial Fibrillation

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Clinicians who have experience using low dose fluoroscopy including use of Carto Mapping system will consent patients to allow data collection and a 12 month f/up visit to track adverse events. Clinicians will follow a protocol which will be similar to their standard of care for ablations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ablation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient meets accepted AHA/ACC/HRS guideline indications for catheter ablation of paroxysmal or persistent AF
* First or subsequent ablation procedures may be included
* Age 18-75

Exclusion Criteria

* Known venous malformations or implanted instrumentation (IVC filter)
* Known PV stenosis
* Unable to provide consent
* H/O mechanical mitral valve replacement (unable to rely on EA mapping only)
* Documented left atrial thrombus
* Prior ASD repair Pregnancy
* NYHA \>=3
* EF less than 35%
* CHF within 90 daysRecent MI or coronary revascularization within 90 days
* Patients who are undergoing non- standard of care ablations ie, Cyro or FIRM ablations

Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No